You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Antibody-Biocide Fusions to Control Cryptosporidium

    SBC: IOGENETICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this research is develop therapeutic products for Cryptosporidium parvum which can be made at a scale and cost which are feasible for delivery to large populations of patients or individuals at risk, as may be necessary in countering bioterrorism, or in protecting field-deployed armed forces. Our approach is to develop recombinant neutralizing mon ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  2. An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hypertension

    SBC: Pulmokine, Inc.            Topic: NHLBI

    DESCRIPTION provided by applicant Pulmokine is developing a novel inhaled PDGF receptor PDGFR kinase inhibitor PK as a treatment for Pulmonary Arterial Hypertension PAH The purpose of this Phase IIB Small Market Bridge Award is to progress PK through a phase A clinical trial for safety PAH is an orphan disease with high morbidity and mortality despite currently available treat ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. Clinical and Non Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology

    SBC: PHARMACOPHOTONICS, INC.            Topic: 400

    DESCRIPTION provided by applicant Pharmaco Photonics DBA FAST Biomedical proposes a PHASE IIB project to determine the safety and functionality of repeat administration of the FAST PV and mGFR Technology in both non clinical and clinical studies The long term goal of this SBIR project is to test FASTandapos s fluorescent based test in humans and commercializes this product for rapid detecti ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. A Metabolism Based Test to Diagnose Autism Spectrum Disorder and its Subtypes in Early Childhood

    SBC: STEMINA BIOMARKER DISCOVERY, INC            Topic: 101

    DESCRIPTION provided by applicant Autism spectrum disorder ASD is now diagnosed in of children with recent reports citing as many as in children in the United States The average age of diagnosis is more than years There is a need for a reliable biomarker based test for earlier diagnosis of ASD in young children to improve outcomes such as cognition social function and communic ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. Workscope Optimization for Engine Repair and Overhaul

    SBC: Impact Technologies            Topic: AF05186

    Impact Technologies, in cooperation with Standard Aero and Northrop Grumman, will lead an effort to develop a web-based software tool capable of optimizing the maintenance repair and overhaul work scopes associated with gas turbine engines that yield realistic cost estimates on a per engine flying hour basis, including post-maintenance performance metrics and expected time on wing predictions. Th ...

    SBIR Phase II 2006 Department of DefenseAir Force
  6. Antimicrobial, Angiogenic Skin Substitutes for Diabetic*

    SBC: Stratatech Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this application is to develop a genetically engineered therapeutic human skin substitute with enhanced antimicrobial and angiogenenic properties for use in the treatment of type 1 diabetic skin ulcers. Chronic diabetic skin ulcers exhibit poor blood flow and typically become infected resulting in impaired wound healing and amputation, a life thr ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  7. In vivo Thermoacoustic Imaging of HER2 Status

    SBC: OPTOSONICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In this Fast Track application, we propose developing the novel imaging technology and molecular probe that will enable the non-invasive detection and quantification of HER2 overexpression in breast cancers. The approach we are promoting is to label Herceptin, a therapeutic mono-clonal antibody, with an infraredabsorbing dye, and then to detect the presence ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  8. Point-of-care Detection of HIV Antibodies and RNA in Blood and Saliva

    SBC: RHEONIX, INC.            Topic: NIDCR

    DESCRIPTION provided by applicant The global HIV AIDS epidemic continues to be fueled by the large number of individuals who do not know that they are infected The CDC is supporting programs to decrease this number by encouraging more frequent testing of all age groups as well as increasing the venues for testing including the recent FDA approval of an oral HIV Screening test for anti HIV anti ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer

    SBC: CANGET BIOTEKPHARMA, LLC            Topic: 102

    Abstract The goal of this fast track SBIR proposal is to file an investigational new drugINDapplication for testing a novel anticancer drugFLthat is designed to overcome inherent and acquired treatment resistanceMany types of cancers are not detected until they are very advanced and have already become resistant to FDA approved treatmentsIn additionmany non advanced cancers respond well to initial ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Aerodynamic Dome Manufacturing Cost Reduction

    SBC: OPTIPRO SYSTEMS, LLC            Topic: N132121

    Future missile systems will abandon the traditional hemi-spherical shape for shapes resembling a tangent Ogive. An ogive shaped dome has better aerodynamic capabilities than its spherical counterpart. This enables the missile to fly faster, farther, and with more accuracy while also increasing its payload capacity. The optical material of choice is polycrystalline alumina, PCA, which is a hard cer ...

    SBIR Phase II 2015 Department of DefenseNavy
US Flag An Official Website of the United States Government